Peter E. Westerweel

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 587 citations · Full text

Hematological Malignancy, Medicine, Chronic Myeloid Leukaemia +10

Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients

Harry Dolstra, Mieke W.H. Roeven, Jan Spanholtz et al. · Clinical Cancer Research · 2017 · 203 citations

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial

Stefano Barco, Irene Schmidtmann, Walter Ageno et al. · European Heart Journal · 2019 · 151 citations · Full text

The Use of Endothelial Progenitor Cells for Prevascularized Bone Tissue Engineering

Jeroen Rouwkema, Peter E. Westerweel, Jan de Boer et al. · Tissue Engineering Part A · 2009 · 118 citations · Full text

Progenitor Cells, Tissue Engineering, Engineering +21

Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus

Peter E. Westerweel, Remco K.M.A.C. Luijten, Imo E. Hoefer et al. · Annals of the Rheumatic Diseases · 2007 · 113 citations · Full text